FDA Clearance Tracker · P210037-S006
Prospera SCS System, Resilience Surgical Lead, Embrace One
Last checked: Nov 20, 2026Latest source record: Mar 24, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 24, 2025
Approved
Time to decision
327 days
Received May 1, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P210037-S006
- Device name
- Prospera SCS System, Resilience Surgical Lead, Embrace One
- Applicant
- Biotronik Nro, Inc.
- Applicant location
- Lake Oswego, OR
- Received
- May 1, 2024
- Decided
- Mar 24, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P210037
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for changes made to update the Clinician Programmer Application (CP App), Patient Remote Application (PR App), and Neuro Service Center (NSC). Specifically, changes were made to update the Clinician Programmer Application to version 2.9.5 which includes changes such as bug removals, minor improvements, default value for stimulation mode has been changed to Multiphase, corrected ViStim formula to allow intended therapy programming range, changed lower limit for electrode failure from 200 Ohm to 100 Ohm, and reduction of Clinician Programmer Application startup time. Patient Remote Application to version 2.9.5 which includes changes such as bug removals, minor improvements, and reduced startup time for PR App. Neuro Service Center updated to 1.5.89 which includes changes such as bug fixes and minor improvements.
Source documents
Other decisions for Biotronik Nro, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P210037 · Decided Mar 31, 2023 · 484 days after receipt
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.